Key result
Despite long-standing knowledge of myocardial reperfusion syndrome in STEMI patients, there remains no unequivocal consensus on its predictors, hindering effective risk stratification and prevention.
Why the study?
There is no unequivocal opinion regarding the predictors and risk groups for myocardial reperfusion syndrome in patients with ST-segment elevation myocardial infarction.
What are the predictors of myocardial reperfusion syndrome in patients with ST-segment elevation myocardial infarction?
What are the predictors of myocardial reperfusion syndrome in patients with ST-segment elevation myocardial infarction?
Answers are grounded in this paper and cite their sources.
The review highlights the ongoing challenge of predicting myocardial reperfusion syndrome in STEMI patients, noting that while some predictors for arrhythmias exist, markers for reperfusion injury and stunning are still needed.
Myocardial reperfusion syndrome is a complex set of pathological processes that occur in the heart muscle due to restoration of coronary blood flow in patients with ST-segment elevation myocardial infarction. Despite the fact that it has been known for a long time, there is still no unequivocal opinion about the predictors, and, accordingly, the risk groups for its occurrence. This prevents predicting the further course of the disease and studying the effectiveness of surgical and therapeutic methods for preventing the consequences of reperfusion in patients with ST-segment elevation myocardial infarction, which in turn significantly worsens the postoperative and long-term prognosis in this group of patients. We used the search engines such as E-lilbrary, Google Scholar and Pubmed to search for studies on this issue. The article presents research data highlighting predictors of myocardial reperfusion syndrome. In addition, the problems of verification of irreversible reperfusion injury and myocardial stunning are described.
No takes yet. Share an insight, caveat, or question.
Хубулава et al. (2021) conducted a review in ST-segment elevation myocardial infarction (STEMI) and myocardial reperfusion syndrome. Reperfusion therapy was evaluated. Despite long-standing knowledge of myocardial reperfusion syndrome in STEMI patients, there remains no unequivocal consensus on its predictors, hindering effective risk stratification and prevention.
Synapse has enriched 10 related papers. Consider them for comparative context: